multicenter trial refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or
暂无分享,去创建一个
L. Gordon | J. Murray | T. Witzig | G. Wiseman | R. Schilder | S. Spies | P. Multani | C. White | M. Saleh | A. Grillo‐López | L. Nancy | R. Allen